The role of fractalkine in the development of diabetic macular edema in patients with type 2 diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 1
Abstract
Background. Diabetic macular edema (DME) is a severe complication of type 2 diabetes mellitus (DM) and a leading cause of vision loss in the working age population of most developed countries. The gold standard for DME treatment should be based on a good control of glycemia along with control of lipids and renal function. However, despite the systemic metabolic control values being essential for patients with diabetic retinopathy, it has proven to be insufficient for DME if it appears. In these patients, additional measures are needed in order to avoid the subsequent loss of vision. The aim of the work was to assess the content of blood fractalkine in patients with type 2 DM and DME in conjunction with the indicators of the thickness of the macula layers. Materials and methods. The study involved 82 patients with type 2 DM (145 eyes), divided into 4 groups in accordance with the DME form. The average age of patients was 65.25 ± 10.85 years, the average duration of DM — 14.00 ± 7.05 years, the average level of HbA1c — 8.40 ± 1.58 %. Results. Using analysis of variance and regression analysis, methods for constructing logistic regression models, we have shown that fractalkine is not associated with the risk of not low values (> QI) of nerve fiber layer, ganglion cell layer, inner plexiform layer, central sector of macula, thickness of fovea. Conclusions. Fractalkine may be a promising new therapeutic method for the treatment of diabetic retinal diseases. DME tends to be a chronic disease, although spontaneous recovery is not uncommon. It is important to recognize that 35 % of patients with macular edema had spontaneous resolution after 6 months if untreated.
Authors and Affiliations
M. L. Kyryliuk, S. А. Suk, S. O. Rykov, S. Yu. Mogilevskyy
Keywords
Related Articles
- EP ID EP535819
- DOI 10.22141/2224-0721.15.1.2019.158686
- Views 56
- Downloads 0
Modern approaches to the laboratory diagnosis and management of hyperthyroidism syndrome
The lecture considers the questions of etiology, pathogeny and early diagnosis of hyperthyro- idism based on modern international guidelines. The differential diagnosis and role of laboratory methods in the treatment of...
The Role of Thyroid Hormones in the Development of Atrial Fibrillation in Thyroid Pathology
The article describes the effects of thyroid hormones on the cardiovascular system, their role in the development of cardiac arrhythmias and, particularly, atrial fibrillation. The clinical manifestations and current gui...
ORIGIN Trial (Background, Results)
ORIGIN — the longest and most extensive study on Lantus® use in patients with cardiovascular risk with diabetes mellitus (DM) type 2 in the early stages, as well as prediabetes, in which insulin therapy is not indicated...
Peculiarities of changes in anticoagulant and coagulant activity in patients with coronary artery disease combined with type 2 diabetes mellitus
Background. Determining the features of regulatory mechanisms of plasma hemostasis in patients with coronary artery disease (CAD) and concomitant type 2 diabetes mellitus (DM) is of theoretical and practical interest, as...
The place of the third generation sulfonylurea glimepiride in modern therapy of type 2 diabetes mellitus
The article considers the pharmacological and clinical aspects of the use of glimepiride, a third generation sulfonylurea, in modern therapy of type 2 diabetes mellitus. The drug is characterized by proven efficacy and s...